Search Results 1761-1770 of 20749 for Informed consent
Phase 1b dose escalation cohort patients must be 18 – 65 years old at the time of providing voluntary written informed consent. Phase 3 or any Phase1b dose ...
... informed consent, with a plasma biomarker result that is predictive of intermediate or elevated brain amyloid at Screening or known before Screening to have ...
Be willing and able to provide written informed consent. Exclusion Criteria: Have received more than 2 prior systemic treatment regimens for mSTS; Have ...
Signed informed consent, by the participant or a legally acceptable representative; Aged at least 18 years; Initiating vedolizumab or another biologic agent ...
Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and ...
Ability to understand and the willingness to sign a written informed consent document. Willing to discontinue taking NSAIDS for 30 days prior to initiation ...
... inform her treating physician immediately. Ability to understand and the willingness to sign a written informed consent document. IMAGING CORRELATIVE STUDY ...
Participant provides informed consent and expresses understanding of the protocol and its requirements, risks, and discomforts. Participating Mayo Clinic ...
... inform her treating physician immediately. The ability to understand and the willingness to sign a written informed consent document. Participant must be ...
Capable of giving written consent on an Institutional Review Board or IRB-approved Informed Consent Form prior to any study-specific evaluation. Have a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!